CTD Chemicals (CC): Uracil 

Root: CC Hierarchy (CTD chemicals from Comparative Toxicogenomics Database)

Shortest distance to current term (+ for parents, - for children)	CC term [CC ID] <#Children>	#Domains (Superfamily|Family)	#Supra-domain (Single|Duplex|Triple)
+ + + + + 5:	Chemicals [MESH:D] <13>
+ + + + 4:	Heterocyclic Compounds [MESH:D006571] <181>	(563|748)	(566|486|238)
+ + + 3:	Heterocyclic Compounds, 1-Ring [MESH:D006573] <233>	(504|683)	(511|459|233)
+ + 2:	Pyrimidines [MESH:D011743] <1633>	(155|213)	(162|138|81)
+ 1:	Pyrimidinones [MESH:D011744] <424>	(47|48)	(49|29|9)
0:	Uracil [MESH:D014498] <266>	(26|24)	(27|16|5)
- 1:	Fluorouracil [MESH:D005472] <271>	(16|17)	(17|13|5)
- 1:	Thymine [MESH:D013941] <93>	(0|0)	(0|0|0)
- 1:	Orotic Acid [MESH:D009963] <26>	(1|0)	(1|0|0)
- 1:	Thiouracil [MESH:D013889] <24>	(3|1)	(3|0|0)
- 1:	Bromouracil [MESH:D001976] <10>	(0|0)	(0|0|0)
- 1:	Uracil Mustard [MESH:D014499] <3>	(0|0)	(0|0|0)
- 1:	Pentoxyl [MESH:D010432] <2>	(0|0)	(0|0|0)
- 1:	(4-(6-chloro-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl)butyl) 1-phosphate [MESH:C515409]	(0|0)	(0|0|0)
- 1:	(6-amino-1-methyl-5-nitrosouracilato-N3)triphenylphosphinegold(I) [MESH:C584133]	(0|0)	(0|0|0)
- 1:	(E)-5-(2-(N-(2-(N6-adeninyl)ethyl))carbamylvinyl)-uracil [MESH:C585546]	(0|0)	(0|0|0)
- 1:	(S)-glycoxyuracil [MESH:C585668]	(0|0)	(0|0|0)
- 1:	1,1'(2''-bromo-2''-chloroethenyl)-bis-(5-nitrouracil) [MESH:C401663]	(0|0)	(0|0|0)
- 1:	1,1'(2''-bromo-2'-chloroethenyl)-bis-(5-methyluracile) [MESH:C401664]	(0|0)	(0|0|0)
- 1:	1,3,6-trimethyluracil [MESH:C059618]	(0|0)	(0|0|0)
- 1:	1,3-dimethyluracil [MESH:C002451]	(0|0)	(0|0|0)
- 1:	1-((2-hydroxy-1(hydroxymethyl)ethoxy)methyl)-5-vinyluracil [MESH:C443751]	(0|0)	(0|0|0)
- 1:	1-((2-hydroxy-1-(aminomethyl)ethoxy)methyl)-5-benzyluracil [MESH:C044784]	(0|0)	(0|0|0)
- 1:	1-((2-hydroxy-1-(hydroxymethyl)ethoxy)methyl)-5-benzyluracil [MESH:C044783]	(0|0)	(0|0|0)
- 1:	1-((2-hydroxyethoxy)methyl)-5-(phenylselenenyl)uracil [MESH:C085082]	(0|0)	(0|0|0)
- 1:	1-((2-hydroxyethoxy)methyl)-5-vinyluracil [MESH:C443749]	(0|0)	(0|0|0)
- 1:	1-(1,3-dihydroxy-2-propoxymethyl)-5,6-tetramethyleneuracil [MESH:C063619]	(0|0)	(0|0|0)
- 1:	1-(2',3',4'-trihydroxycyclopent-1'-yl)-1H-uracil [MESH:C411242]	(0|0)	(0|0|0)
- 1:	1-(2-(hydroxymethyl)-1,3-dioxolan-5-yl)-5-(2-iodovinyl)uracil [MESH:C411152]	(0|0)	(0|0|0)
- 1:	1-(2-C-methyl-beta-D-ribofuranosyl)-uracil [MESH:C548853]	(0|0)	(0|0|0)
- 1:	1-(2-O-(tert-butyldimethylsilyl)-3- deoxy-3-C-hydroxymethyl-5-O-monomethoxytrityl-ribo- pentofuranos [MESH:C442888]	(0|0)	(0|0|0)
- 1:	1-(2-amino-2-carboxyethyl)-3-(2-carboxy-5-phenylthiophene-3-ylmethyl)-5-methylpyrimidine-2,4-dione [MESH:C519517]	(0|0)	(0|0|0)
- 1:	1-(2-amino-2-carboxyethyl)-3-(2-carboxybenzyl)-5-iodopyrimidine-2,4-dione [MESH:C507727]	(0|0)	(0|0|0)
- 1:	1-(2-amino-2-carboxyethyl)-3-(2-carboxythiophene-3-ylmethyl)pyrimidine-2,4-dione [MESH:C518061]	(0|0)	(0|0|0)
- 1:	1-(2-aminopyridin-4-ylmethyl)-6-(3,5-dimethylbenzoyl)-5-isopropyl-1H-pyrimidine-2,4-dione [MESH:C525065]	(0|0)	(0|0|0)
- 1:	1-(2-aminopyridin-4-ylmethyl)-6-(3,5-dimethylbenzoyl)-5-isopropyl-1H-pyrimidine-2,4-dione alanine am [MESH:C525066]	(0|0)	(0|0|0)
- 1:	1-(2-carboxyethyl)uracil [MESH:C037339]	(0|0)	(0|0|0)
- 1:	1-(2-deoxypentofuranosyl)isodialuric acid [MESH:C512425]	(0|0)	(0|0|0)
- 1:	1-(2-hydroxyethoxymethyl)-6-azauracil [MESH:C056285]	(0|0)	(0|0|0)
- 1:	1-(3'-amino-3'-carboxypropyl)uracil [MESH:C064303]	(0|0)	(0|0|0)
- 1:	1-(4-hydroxy-3-(hydroxymethyl)-1-butyl)-5-(1-azido-2-chloroethyl)uracil [MESH:C440620]	(0|0)	(0|0|0)
- 1:	1-(4-hydroxy-3-(hydroxymethyl)1-butyl)-5-vinyluracil [MESH:C443750]	(0|0)	(0|0|0)
- 1:	1-(5-(2-bromovinyl)-2-(hydroxymethyl)-1,3-(dioxolan-4-yl))uracil [MESH:C000598561]	(0|0)	(0|0|0)
- 1:	1-(allyloxymethyl)-6-(3,5-dimethylbenzyl)-5-ethyluracil [MESH:C470204]	(0|0)	(0|0|0)
- 1:	1-UFT protocol [MESH:C031903]	(0|0)	(0|0|0)
- 1:	1-benzoylmethyl-5-(N-pyrrolidino)uracyl [MESH:C558415]	(0|0)	(0|0|0)
- 1:	1-benzyloxymethyl-5-ethyl-6-(alpha-pyridylthio)uracil [MESH:C094217]	(0|0)	(0|0|0)
- 1:	1-calcium phosphate-uracil [MESH:C000598413]	(0|0)	(0|0|0)
- 1:	1-cyclohexyluracil [MESH:C000538]	(0|0)	(0|0|0)
- 1:	1-ethoxymethyl-5-ethyl-6-(3,5-dimethylbenzyl)uracil [MESH:C112359]	(0|0)	(0|0|0)
- 1:	1-hexylcarbamoyluracil [MESH:C411622]	(0|0)	(0|0|0)
- 1:	1-methyluracil [MESH:C002596]	(0|0)	(0|0|0)
- 1:	1-phenyluracil [MESH:C038582]	(0|0)	(0|0|0)
- 1:	1-propyl-3,5-diethyl-6-chlorouracil [MESH:C035518]	(0|0)	(0|0|0)
- 1:	2',3'-dideoxy-4-N-(N-13-(6-(3,5-dimethylphenylthio)-5-ethyl-1-(5-oxopentyl)uracil)-13-azadodecyl)cyt [MESH:C409866]	(0|0)	(0|0|0)
- 1:	2-(3,5-dichloro-4-(5-isopropyl-6-oxo-1,6-dihydropyridazin-3-yloxy)phenyl)-3,5-dioxo-2,3,4,5-tetrahyd [MESH:C588408]	(0|0)	(0|0|0)
- 1:	2-(6-uradinyl)-4,4,5,5-tetramethyl-4,5-dihydro-1H-imidazole-1-oxyl [MESH:C531505]	(0|0)	(0|0|0)
- 1:	2-selenouracil [MESH:C050507]	(0|0)	(0|0|0)
- 1:	3-(2-cyanoethoxy(diisopropylamino)phosphinoxymethyl)-5-N-(4-monomethoxytrityl)-1-(uracil-1-yl)-5-aza [MESH:C433387]	(0|0)	(0|0|0)
- 1:	3-(3,5-dimethylbenzyl)uracil [MESH:C527156]	(0|0)	(0|0|0)
- 1:	3-deazauracil [MESH:C094258]	(0|0)	(0|0|0)
- 1:	3-methyluracil [MESH:C055991]	(0|0)	(0|0|0)
- 1:	4,2'-anhydro-5-arabinofuranosyluracil [MESH:C414938]	(0|0)	(0|0|0)
- 1:	4,5-diamino-1,3-dimethyluracil [MESH:C011756]	(0|0)	(0|0|0)
- 1:	4-(1,3-dibenzyl-1,2,3,4-tetrahydro-2,4-dioxopyrimidin-5-yl)-2-hydroxy-4-oxobut-2-enoic acid [MESH:C508794]	(0|0)	(0|0|0)
- 1:	4-(N-(2-(uracil-6-ylmethyliminooxy)ethyloxy)iminomethyl)benzoic acid [MESH:C515609]	(0|0)	(0|0|0)
- 1:	4-(chloromethyl)uracil [MESH:C024572]	(0|0)	(0|0|0)
- 1:	4-aminomethyluracil [MESH:C012723]	(0|0)	(0|0|0)
- 1:	4-bromo-5,6-dihydroborauracil [MESH:C542502]	(0|0)	(0|0|0)
- 1:	4-hydroxy-3-methylborauracil [MESH:C548923]	(0|0)	(0|0|0)
- 1:	4-hydroxy-5,6-dihydroborauracil [MESH:C542504]	(0|0)	(0|0|0)
- 1:	4-hydroxyborauracil [MESH:C548924]	(0|0)	(0|0|0)
- 1:	4-methoxy-5,6-dihydroborauracil [MESH:C542503]	(0|0)	(0|0|0)
- 1:	5,6-benzocoumarin-5-uracil [MESH:C506801]	(0|0)	(0|0|0)
- 1:	5,6-diamino-2,4-dihydroxypyrimidine [MESH:C061549]	(0|0)	(0|0|0)
- 1:	5,6-dihydrouracil 6-sulfonic acid [MESH:C541630]	(0|0)	(0|0|0)
- 1:	5,6-trimethyleneuracil [MESH:C523560]	(0|0)	(0|0|0)
- 1:	5-((glucopyranosyloxy)methyl)uracil [MESH:C084880]	(0|0)	(0|0|0)
- 1:	5-((hydroxymethyl)-O-pyrophosphoryl)uracil [MESH:C031674]	(0|0)	(0|0|0)
- 1:	5-(1-hydroxyethyl)uracil [MESH:C073778]	(0|0)	(0|0|0)
- 1:	5-(2-bromovinyl)-1-(2-(hydroxymethyl)-1,3-dioxolan-5-yl)uracil [MESH:C411151]	(0|0)	(0|0|0)
- 1:	5-(2-chlorovinyl)-1-(2-(hydroxymethyl)-1,3-dioxolan-5-yl)uracil [MESH:C411150]	(0|0)	(0|0|0)
- 1:	5-(2-oxopropylideneamino)-6-d-ribitylaminouracil [MESH:C000654742]	(0|0)	(0|0|0)
- 1:	5-(2-pyridylethynyl)uracil [MESH:C552107]	(0|0)	(0|0|0)
- 1:	5-(4',5'-dihydroxypentyl)uracil [MESH:C007429]	(0|0)	(0|0|0)
- 1:	5-(4-chlorobenzyl)-6-aminouracil [MESH:C044442]	(0|0)	(0|0|0)
- 1:	5-(5',6'-benzocoumarin-3')-methylaminouracil hydrobromide [MESH:C520473]	(0|0)	(0|0|0)
- 1:	5-(benzyloxybenzyloxybenzyl)acyclouridine [MESH:C055762]	(0|0)	(0|0|0)
- 1:	5-(difluorosulfomethyl)uracil [MESH:C090390]	(0|0)	(0|0|0)
- 1:	5-(perylen-3-ylethynyl)uracil-1-acetic acid [MESH:C000625744]	(0|0)	(0|0|0)
- 1:	5-(phenylselenenyl)acyclouridine [MESH:C408044]	(0|0)	(0|0|0)
- 1:	5-(pyren-1-yl)uracil [MESH:C570985]	(0|0)	(0|0|0)
- 1:	5-S-cysteinyluracil [MESH:C014438]	(0|0)	(0|0|0)
- 1:	5-acetylamino-6-amino-3-methyluracil [MESH:C054188]	(0|0)	(0|0|0)
- 1:	5-acetylamino-6-formylamino-3-methyluracil [MESH:C036692]	(0|0)	(0|0|0)
- 1:	5-acetyluracil [MESH:C575577]	(0|0)	(0|0|0)
- 1:	5-amino-6-D-ribitylaminouracil [MESH:C000626625]	(0|0)	(0|0|0)
- 1:	5-aminouracil [MESH:C011166]	(0|0)	(0|0|0)
- 1:	5-aminouracil-6-sulfonic acid [MESH:C431286]	(0|0)	(0|0|0)
- 1:	5-azauracil [MESH:C039856]	(0|0)	(0|0|0)
- 1:	5-azauracil(2,4-dioxotriazine) [MESH:C000604492]	(0|0)	(0|0|0)
- 1:	5-benzylacyclouridine [MESH:C034753]	(0|0)	(0|0|0)
- 1:	5-benzyloxybenzylacyclouridine [MESH:C034754]	(0|0)	(0|0|0)
- 1:	5-benzyloxybenzylbarbituric acid [MESH:C084557]	(0|0)	(0|0|0)
- 1:	5-benzyloxybenzyluracil [MESH:C068991]	(0|0)	(0|0|0)
- 1:	5-benzyluracil [MESH:C403911]	(0|0)	(0|0|0)
- 1:	5-bromo-1,3-dimethyluracil [MESH:C061430]	(0|0)	(0|0|0)
- 1:	5-bromo-1-mesyluracil [MESH:C506204]	(0|0)	(0|0|0)
- 1:	5-bromo-5,6-dihydrouracil [MESH:C049571]	(0|0)	(0|0|0)
- 1:	5-bromovinyl-(2-hydroxymethyl)-(1,3-dioxolanyl)uracil [MESH:C415375]	(0|0)	(0|0|0)
- 1:	5-chloro-1-(2',3'-dideoxy-3'-fluoro-erythro-pentofuranosyl)uracil [MESH:C422582]	(0|0)	(0|0|0)
- 1:	5-chloro-1-(2,3-dideoxy-3-fluoro-glycero-hex-2- enopyranose-4-ulosyl)uracil [MESH:C442708]	(0|0)	(0|0|0)
- 1:	5-chloro-6-(1-(2-iminopyrrolidinyl) methyl)uracil hydrochloride [MESH:C119063]	(0|0)	(0|0|0)
- 1:	5-chlorocylindrospermopsin [MESH:C513693]	(0|0)	(0|0|0)
- 1:	5-chlorouracil [MESH:C010889]	(0|0)	(0|0|0)
- 1:	5-cyanouracil [MESH:C056431]	(0|0)	(0|0|0)
- 1:	5-cyclohexyl-6-methyluracil [MESH:C069042]	(0|0)	(0|0|0)
- 1:	5-diazouracil [MESH:C004758]	(0|0)	(0|0|0)
- 1:	5-ethyl-1-(3-(2-furyl)prop-2-en-1-yl)-6-(phenylthio)uracil [MESH:C106589]	(0|0)	(0|0|0)
- 1:	5-ethyl-1-(ethoxymethyl)-6-(phenylselenenyl)uracil [MESH:C091742]	(0|0)	(0|0|0)
- 1:	5-ethyl-1-benzyloxymethyl-6-(phenylthio)uracil [MESH:C093181]	(0|0)	(0|0|0)
- 1:	5-ethyl-1-ethoxymethyl-6-(phenylthio)uracil [MESH:C071166]	(0|0)	(0|0|0)
- 1:	5-ethyl-6-(1-naphthylmethyl)uracil [MESH:C107133]	(0|0)	(0|0|0)
- 1:	5-ethyl-6-(phenylthio)-1-(3-(2-thienyl)prop-2-en-1-yl)uracil [MESH:C106590]	(0|0)	(0|0|0)
- 1:	5-ethyluracil [MESH:C048011]	(0|0)	(0|0|0)
- 1:	5-fluoro-1,3-dimethyluracil [MESH:C500872]	(0|0)	(0|0|0)
- 1:	5-fluoro-1-(6-O-acetyl-3,4-di-deoxy-3-fluoro-beta-D-glycero-hex-3-eno-pyranos-2-ulosyl) uracil [MESH:C503849]	(0|0)	(0|0|0)
- 1:	5-fluoro-6-((2-iminopyrrolidin-1-yl)methyl)uracil [MESH:C552315]	(0|0)	(0|0|0)
- 1:	5-formyluracil [MESH:C007777]	(0|0)	(0|0|0)
- 1:	5-hydroxyuracil [MESH:C045975]	(0|0)	(0|0|0)
- 1:	5-iodo-1-(4-thio-arabinofuranosyl)uracil [MESH:C465668]	(0|0)	(0|0|0)
- 1:	5-iodo-5,6-dihydrouracil [MESH:C013573]	(0|0)	(0|0|0)
- 1:	5-iodo-6-((2-iminoimidazolidinyl)methyl)uracil [MESH:C551481]	(0|0)	(0|0|0)
- 1:	5-iodo-6-2-biphenyloxy-1,3-dimethyluracil [MESH:C008141]	(0|0)	(0|0|0)
- 1:	5-iododioxolane uracil [MESH:C419688]	(0|0)	(0|0|0)
- 1:	5-iodouracil [MESH:C048747]	(0|0)	(0|0|0)
- 1:	5-isopropyluracil [MESH:C002653]	(0|0)	(0|0|0)
- 1:	5-mercaptomethyluracil [MESH:C059338]	(0|0)	(0|0|0)
- 1:	5-nitro-6-(3-nitrostyryl)pyrimidine-2,4(1H,3H)-dione [MESH:C000602518]	(0|0)	(0|0|0)
- 1:	5-nitrouracil [MESH:C057449]	(0|0)	(0|0|0)
- 1:	5-propyluracil [MESH:C002652]	(0|0)	(0|0|0)
- 1:	5-propynyluracil [MESH:C083257]	(0|0)	(0|0|0)
- 1:	5-sulfaminouracil [MESH:C000600491]	(0|0)	(0|0|0)
- 1:	5-thiomethyluracil [MESH:C505900]	(0|0)	(0|0|0)
- 1:	5-uracilmethylphosphonate [MESH:C535037]	(0|0)	(0|0|0)
- 1:	5-vinyluracil [MESH:C022859]	(0|0)	(0|0|0)
- 1:	6'-(5-carboxy-1,4-dimethyl-3-oxo-2H,3H-1,4-diazepin-2-yl)uracil [MESH:C451485]	(0|0)	(0|0|0)
- 1:	6,8-diethyl-2-hydroxymethyltetrahydrooxazolo(3,2-c)pyrimidine-5,7-(4H,6H)-dione [MESH:C036237]	(0|0)	(0|0|0)
- 1:	6-((3,5-dimethylphenyl)-thio)-5-ethyl-1-(4-(methoxycarbonyl)butyl)uracil [MESH:C409863]	(0|0)	(0|0|0)
- 1:	6-((3,5-dimethylphenyl)thio)-5-ethyl-1-(3-(2-furyl)prop-2-en-1-yl)uracil [MESH:C106591]	(0|0)	(0|0|0)
- 1:	6-(2-(dimethylamino)vinyl)-1,3-dimethyluracil [MESH:C572569]	(0|0)	(0|0|0)
- 1:	6-(2-aminoethyl)amino-5-chlorouracil [MESH:C545842]	(0|0)	(0|0|0)
- 1:	6-(2-biphenyl)oxy-1,3-dimethyluracil [MESH:C006758]	(0|0)	(0|0|0)
- 1:	6-(3'-ethyl-4'-methylanilino)uracil [MESH:C413944]	(0|0)	(0|0|0)
- 1:	6-(3'-iodo-4'-methylanilino)uracil [MESH:C413943]	(0|0)	(0|0|0)
- 1:	6-(3,5-dimethylbenzyl)-1-(ethoxymethyl)-5-isopropyluracil [MESH:C510377]	(0|0)	(0|0|0)
- 1:	6-(3,5-dimethylbenzyl)-5-ethyl-1-(3-methylbut-2-enyloxymethyl)uracil [MESH:C470205]	(0|0)	(0|0|0)
- 1:	6-(4-hydroxyphenylhydrazino)uracil [MESH:C011284]	(0|0)	(0|0|0)
- 1:	6-(N-octylanilino)uracil [MESH:C095137]	(0|0)	(0|0|0)
- 1:	6-amino-1,3-dimethyl uracil [MESH:C479868]	(0|0)	(0|0|0)
- 1:	6-amino-1-benzyl-3-(3,5-dimethylbenzyl)uracil [MESH:C574279]	(0|0)	(0|0|0)
- 1:	6-amino-1-methyl-5-nitrosouracil [MESH:C498098]	(0|0)	(0|0|0)
- 1:	6-amino-3-(3,5-dimethylbenzyl)-1-(4-picolyl)uracil [MESH:C587144]	(0|0)	(0|0|0)
- 1:	6-amino-3-methyluracil-5-carbaldehyde [MESH:C543555]	(0|0)	(0|0|0)
- 1:	6-amino-5-(N-methylformylamino)-1-methyluracil [MESH:C066068]	(0|0)	(0|0|0)
- 1:	6-amino-5-(benzylamino)uracil [MESH:C572752]	(0|0)	(0|0|0)
- 1:	6-amino-5-(formyl-N-methylamino)-1,3-dimethyluracil [MESH:C029567]	(0|0)	(0|0|0)
- 1:	6-amino-5-bromo-1-(8-phosphonooctyl)uracil [MESH:C406231]	(0|0)	(0|0|0)
- 1:	6-aminouracil [MESH:C013400]	(0|0)	(0|0|0)
- 1:	6-aminouracil (6-amino-2,4-pyrimidinediol) [MESH:C575904]	(0|0)	(0|0|0)
- 1:	6-azido-1-benzyl-3-(3,5-dimethylbenzyl)uracil [MESH:C574278]	(0|0)	(0|0|0)
- 1:	6-benzyl-1-benzyloxymethyl-5-iodouracil [MESH:C000608213]	(0|0)	(0|0|0)
- 1:	6-benzylidenehydrazino-1,3-dimethyluracil [MESH:C113252]	(0|0)	(0|0|0)
- 1:	6-bromouracil [MESH:C044977]	(0|0)	(0|0|0)
- 1:	6-chloro-1,3-dimethyluracil [MESH:C070275]	(0|0)	(0|0|0)
- 1:	6-chloro-5-(2-propenyl)-uracil [MESH:C110989]	(0|0)	(0|0|0)
- 1:	6-chloro-5-cyclopent-1-en-1-yluracil [MESH:C526813]	(0|0)	(0|0|0)
- 1:	6-chlorouracil [MESH:C044976]	(0|0)	(0|0|0)
- 1:	6-ethynyluracil [MESH:C036158]	(0|0)	(0|0|0)
- 1:	6-iodouracil [MESH:C044978]	(0|0)	(0|0|0)
- 1:	6-methyl-2-selenouracil [MESH:C079083]	(0|0)	(0|0|0)
- 1:	6-methyluracil [MESH:C008378]	(0|0)	(0|0|0)
- 1:	6-n-propyluracil [MESH:C056698]	(0|0)	(0|0|0)
- 1:	6-propyl-2-selenouracil [MESH:C079082]	(0|0)	(0|0|0)
- 1:	6-uracilmethylphosphonate [MESH:C535038]	(0|0)	(0|0|0)
- 1:	7-deoxycylindrospermopsin [MESH:C513692]	(0|0)	(0|0|0)
- 1:	A 73209 [MESH:C086564]	(0|0)	(0|0|0)
- 1:	A 90289A [MESH:C548455]	(0|0)	(0|0|0)
- 1:	A 90289B [MESH:C548456]	(0|0)	(0|0|0)
- 1:	ABT-333 [MESH:C588260]	(0|0)	(0|0|0)
- 1:	AR C155858 [MESH:C546977]	(0|0)	(0|0|0)
- 1:	Agent No. 547 [MESH:C461221]	(0|0)	(0|0|0)
- 1:	B 695-40 [MESH:C058690]	(0|0)	(0|0|0)
- 1:	C-547 compound [MESH:C449662]	(0|0)	(0|0|0)
- 1:	CE 224,535 [MESH:C562356]	(0|0)	(0|0|0)
- 1:	CMU protocol [MESH:C059176]	(0|0)	(0|0|0)
- 1:	COPU protocol [MESH:C061125]	(0|0)	(0|0|0)
- 1:	CX 659S [MESH:C418807]	(0|0)	(0|0|0)
- 1:	FAP regimen [MESH:C057624]	(0|0)	(0|0|0)
- 1:	FCE 24379 [MESH:C059156]	(0|0)	(0|0|0)
- 1:	FEP protocol [MESH:C057623]	(0|0)	(0|0|0)
- 1:	FEPA protocol [MESH:C061422]	(0|0)	(0|0|0)
- 1:	FP protocol [MESH:C092424]	(0|0)	(0|0|0)
- 1:	Hydroxyphenylazouracil [MESH:D006906]	(0|0)	(0|0|0)
- 1:	KIN-52 [MESH:C471127]	(0|0)	(0|0|0)
- 1:	MQF-OK-UFT protocol [MESH:C056588]	(0|0)	(0|0|0)
- 1:	MYK-461 [MESH:C000605992]	(0|0)	(0|0|0)
- 1:	N(1),N(3)-diallyl-6-methyluracil [MESH:C056087]	(0|0)	(0|0|0)
- 1:	N(1),N(3)-diallyluracil [MESH:C056088]	(0|0)	(0|0|0)
- 1:	N(1)-cyclopentyl-5-nitropyrimidine-2,4-dione [MESH:C045263]	(0|0)	(0|0|0)
- 1:	N-(1-(3-(cyclopropylmethoxy)-4-fluorophenyl)ethyl)-3-((2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)metho [MESH:C574630]	(0|0)	(0|0|0)
- 1:	N-(1-(3-(cyclopropylmethoxy)phenyl)ethyl)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)pent-3-ene-1-su [MESH:C575285]	(0|0)	(0|0|0)
- 1:	N-(2-(hydroxyethoxy)methyl)-5-methyluracil [MESH:C046151]	(0|0)	(0|0|0)
- 1:	N-nitrosodihydrouracil [MESH:C585160]	(0|0)	(0|0|0)
- 1:	PMU protocol [MESH:C055427]	(0|0)	(0|0|0)
- 1:	PMUE protocol [MESH:C066689]	(0|0)	(0|0|0)
- 1:	ReCl(CO)3-6-amino-1,3-dimethyl-5-nitrosouracil [MESH:C504118]	(0|0)	(0|0|0)
- 1:	SMIFH2 compound [MESH:C547376]	(0|0)	(0|0|0)
- 1:	TEGAFOX protocol [MESH:C507844]	(0|0)	(0|0|0)
- 1:	UFD 1 protocol [MESH:C038468]	(0|0)	(0|0|0)
- 1:	UFT(R) drug [MESH:C096910]	(0|0)	(0|0|0)
- 1:	UFTM protocol [MESH:C040961]	(0|0)	(0|0|0)
- 1:	VAU regimen [MESH:C077021]	(0|0)	(0|0|0)
- 1:	Viekira Pak [MESH:C000607373]	(0|0)	(0|0|0)
- 1:	acluracil [MESH:C012696]	(0|0)	(0|0|0)
- 1:	adenine-uracil dimers [MESH:C034537]	(0|0)	(0|0|0)
- 1:	alogliptin [MESH:C520853]	(0|0)	(0|0|0)
- 1:	amigluracil [MESH:C014314]	(0|0)	(0|0|0)
- 1:	azauracil [MESH:C100248]	(0|0)	(0|0|0)
- 1:	betamecil [MESH:C526126]	(0|0)	(0|0|0)
- 1:	bis-(1,3-dimethyluracil)dichlorocopper(II) [MESH:C018466]	(0|0)	(0|0|0)
- 1:	bis-(N,N'-uracil-1-yl)selenoxomethane [MESH:C056973]	(0|0)	(0|0|0)
- 1:	butylanilinouracil [MESH:C024095]	(0|0)	(0|0|0)
- 1:	cyclopentenyluracil [MESH:C068989]	(0|0)	(0|0|0)
- 1:	cylindrospermopsin [MESH:C089595]	(6|4)	(6|1|0)
- 1:	dapsone, methyluracil drug combination [MESH:C040893]	(0|0)	(0|0|0)
- 1:	deoxymalayamicin A [MESH:C534161]	(0|0)	(0|0|0)
- 1:	diaqua(5,5'-(pyridine-2,6-diylbis(methylidynenitrilo))bis(pyrimidine-2,4(1H,3H)-dione))zinc(II) [MESH:C520989]	(0|0)	(0|0|0)
- 1:	dihydrouracil [MESH:C007419]	(0|0)	(0|0|0)
- 1:	dioxicol [MESH:C060081]	(0|0)	(0|0|0)
- 1:	diucifon [MESH:C023367]	(0|0)	(0|0|0)
- 1:	emivirine [MESH:C083858]	(0|0)	(0|0|0)
- 1:	eniluracil [MESH:C073482]	(0|0)	(0|0|0)
- 1:	iodouracil [MESH:C100034]	(0|0)	(0|0|0)
- 1:	isodialuric acid [MESH:C093681]	(0|0)	(0|0|0)
- 1:	lenacil [MESH:C016490]	(0|0)	(0|0|0)
- 1:	levomecol [MESH:C054376]	(0|0)	(0|0|0)
- 1:	metariboadenosine triphosphorous [MESH:C016558]	(0|0)	(0|0|0)
- 1:	methuracol [MESH:C031322]	(0|0)	(0|0|0)
- 1:	methyl 6-aminouracil-5-carbodithioates [MESH:C024604]	(0|0)	(0|0|0)
- 1:	nikkomycin L(x) [MESH:C121128]	(0|0)	(0|0|0)
- 1:	nikkomycin L(z) [MESH:C121129]	(0|0)	(0|0|0)
- 1:	nikkomycin S(Z) [MESH:C073930]	(0|0)	(0|0|0)
- 1:	nikkomycin So(Z) [MESH:C073933]	(0|0)	(0|0|0)
- 1:	oxymethacil [MESH:C003029]	(0|0)	(0|0|0)
- 1:	platenocidin [MESH:C015456]	(0|0)	(0|0|0)
- 1:	platinum uracil blue [MESH:C011996]	(0|0)	(0|0|0)
- 1:	streptourosol [MESH:C009834]	(0|0)	(0|0|0)
- 1:	streptovirudin [MESH:C009329]	(0|0)	(0|0|0)
- 1:	terbacil [MESH:C011362]	(0|0)	(0|0|0)
- 1:	tetrazolo(5,4-a)-6-methyluracil [MESH:C010818]	(0|0)	(0|0|0)
- 1:	tetrazolo(5,4-a)-6-propyluracil [MESH:C010819]	(0|0)	(0|0|0)
- 1:	trelagliptin [MESH:C000595449]	(0|0)	(0|0|0)
- 1:	trifluridine and tipiracil [MESH:C000613803]	(0|0)	(0|0|0)
- 1:	tunicaminyluracil [MESH:C514546]	(0|0)	(0|0|0)
- 1:	uracil glycol [MESH:C111900]	(0|0)	(0|0|0)
- 1:	uracil polyoxin C [MESH:C414026]	(0|0)	(0|0|0)
- 1:	uracil-2-propenal [MESH:C048058]	(0|0)	(0|0|0)
- 1:	uracil-5-carboxylic acid [MESH:C003745]	(0|0)	(0|0|0)
- 1:	uracil-progesterone [MESH:C038350]	(0|0)	(0|0|0)
- 1:	uracil-spyrodihydroindolizine [MESH:C467358]	(0|0)	(0|0|0)
- 1:	willardiine [MESH:C002872]	(0|0)	(0|0|0)

Superfamily

Highlighted in gray are those with FDR_all>0.001

SCOP term	FDR (all)	Annotation (direct or inherited)
Inhibitor of apoptosis (IAP) repeat	0.0000001398	DIRECT
Caspase-like	0.000002356	DIRECT
Bcl-2 inhibitors of programmed cell death	0.0001655	DIRECT
BTG domain-like	0.0004764	DIRECT
Purine and uridine phosphorylases	0.000816	DIRECT
PurM N-terminal domain-like	0.000816	DIRECT
PurM C-terminal domain-like	0.000816	DIRECT
DNA clamp	0.00319	INHERITED FROM: cylindrospermopsin
Cyclin-like	0.003295	INHERITED FROM: Fluorouracil
FnI-like domain	0.004912	INHERITED FROM: Fluorouracil
TNF receptor-like	0.006494	INHERITED FROM: Fluorouracil
p53-like transcription factors	0.006694	INHERITED FROM: Thiouracil
alpha/beta knot	0.007735	INHERITED FROM: cylindrospermopsin
Protein kinase-like (PK-like)	0.0119	INHERITED FROM: Orotic Acid || Folfox protocol
ABC transporter transmembrane region	0.02709	INHERITED FROM: Fluorouracil
A DNA-binding domain in eukaryotic transcription factors	0.03676	INHERITED FROM: Fluorouracil
EGF/Laminin	0.03938	INHERITED FROM: Propylthiouracil
GLA-domain	0.05506	INHERITED FROM: CMF protocol
L30e-like	0.05506	INHERITED FROM: cylindrospermopsin
Growth factor receptor domain	0.0743	INHERITED FROM: CMF regimen || Folfox protocol
Leucine zipper domain	0.0992	INHERITED FROM: cylindrospermopsin
4-helical cytokines	0.1255	INHERITED FROM: FEC protocol
S-adenosyl-L-methionine-dependent methyltransferases	0.1504	INHERITED FROM: cylindrospermopsin
Cytochrome P450	0.2367	INHERITED FROM: cylindrospermopsin
SH2 domain	0.2565	INHERITED FROM: Methylthiouracil
L domain-like	0.957	INHERITED FROM: CMF regimen || Folfox protocol

Family

Highlighted in gray are those with FDR_all>0.001

SCOP term	FDR (all)	Annotation (direct or inherited)
Inhibitor of apoptosis (IAP) repeat	0.0000001581	DIRECT
L domain	0.00007046	DIRECT
Caspase catalytic domain	0.00009745	DIRECT
Cell cycle control phosphatase, catalytic domain	0.0001036	DIRECT
Bcl-2 inhibitors of programmed cell death	0.0001969	DIRECT
BTG domain-like	0.000497	DIRECT
Polo-box duplicated region	0.0008132	DIRECT
PurM C-terminal domain-like	0.0008132	DIRECT
PurM N-terminal domain-like	0.0008132	DIRECT
Purine and uridine phosphorylases	0.0008132	DIRECT
Cyclin	0.003064	INHERITED FROM: Fluorouracil
ABC transporter transmembrane region	0.00597	INHERITED FROM: Fluorouracil
TNF receptor-like	0.007479	INHERITED FROM: Fluorouracil
Dual specificity phosphatase-like	0.03228	INHERITED FROM: cylindrospermopsin
A DNA-binding domain in eukaryotic transcription factors	0.04106	INHERITED FROM: Fluorouracil
Protein kinases, catalytic subunit	0.04736	INHERITED FROM: Folfox protocol
GLA-domain	0.05848	INHERITED FROM: CMF protocol
Cell cycle transcription factor e2f-dp	0.05848	INHERITED FROM: Fluorouracil
DNA replication initiator (cdc21/cdc54) N-terminal domain	0.05848	INHERITED FROM: Fluorouracil
Leucine zipper domain	0.1216	INHERITED FROM: cylindrospermopsin
Growth factor receptor domain	0.1254	INHERITED FROM: CMF regimen || Folfox protocol
Cytochrome P450	0.2193	INHERITED FROM: cylindrospermopsin
SH2 domain	0.2979	INHERITED FROM: Methylthiouracil
UDPGT-like	0.4054	INHERITED FROM: cylindrospermopsin

Supra-domain (Single|Duplex|Triple)

Supra-domain (Single)

Highlighted in gray are those with FDR>0.001

Supra-domain (Single)	FDR (all)	Annotation (direct or inherited)
Inhibitor of apoptosis (IAP) repeat	0.00000006152	DIRECT
Caspase-like	0.000001109	DIRECT
Bcl-2 inhibitors of programmed cell death	0.00009068	DIRECT
BTG domain-like	0.0002739	DIRECT
PurM N-terminal domain-like	0.0004822	DIRECT
PurM C-terminal domain-like	0.0004822	DIRECT
Purine and uridine phosphorylases	0.0004822	DIRECT
DNA clamp	0.002021	INHERITED FROM: cylindrospermopsin
Cyclin-like	0.002089	INHERITED FROM: Fluorouracil
FnI-like domain	0.003177	INHERITED FROM: Fluorouracil
TNF receptor-like	0.00427	INHERITED FROM: Fluorouracil
p53-like transcription factors	0.004409	INHERITED FROM: Thiouracil
alpha/beta knot	0.005141	INHERITED FROM: cylindrospermopsin
Protein kinase-like (PK-like)	0.008096	INHERITED FROM: Orotic Acid || Folfox protocol
ABC transporter transmembrane region	0.01936	INHERITED FROM: Fluorouracil
A DNA-binding domain in eukaryotic transcription factors	0.02673	INHERITED FROM: Fluorouracil
EGF/Laminin	0.02875	INHERITED FROM: Propylthiouracil
GLA-domain	0.04094	INHERITED FROM: CMF protocol
L30e-like	0.04094	INHERITED FROM: cylindrospermopsin
NAD(P)-linked oxidoreductase	0.05065	INHERITED FROM: Fluorouracil
Growth factor receptor domain	0.0562	INHERITED FROM: CMF regimen || Folfox protocol
Leucine zipper domain	0.07624	INHERITED FROM: cylindrospermopsin
4-helical cytokines	0.09773	INHERITED FROM: FEC protocol
S-adenosyl-L-methionine-dependent methyltransferases	0.1184	INHERITED FROM: cylindrospermopsin
Cytochrome P450	0.1924	INHERITED FROM: cylindrospermopsin
SH2 domain	0.2097	INHERITED FROM: Methylthiouracil || Thiouracil
L domain-like	0.8996	INHERITED FROM: CMF regimen || Folfox protocol

Supra-domain (Duplex) in N- to C-terminal order

Highlighted in gray are those with FDR>0.001

Supra-domain (Duplex) in N- to C-terminal order	FDR (all)	Annotation (direct or inherited)
57924,57924 57924 - Inhibitor of apoptosis (IAP) repeat 57924 - Inhibitor of apoptosis (IAP) repeat	0	DIRECT
57184,52058 57184 - Growth factor receptor domain 52058 - L domain-like	0.00003471	DIRECT
52058,57184 52058 - L domain-like 57184 - Growth factor receptor domain	0.00003471	DIRECT
47986,52129 47986 - DEATH domain 52129 - Caspase-like	0.0003184	DIRECT
82615,82615 82615 - Polo-box domain 82615 - Polo-box domain	0.0004822	DIRECT
55326,56042 55326 - PurM N-terminal domain-like 56042 - PurM C-terminal domain-like	0.0004822	DIRECT
55874,54211 55874 - ATPase domain of HSP90 chaperone/DNA topoisomerase II/histidine kinase 54211 - Ribosomal protein S5 domain 2-like	0.0008275	DIRECT
47113,-7 47113 - Histone-fold -7 - CATH	0.0008537	DIRECT
52821,52799 52821 - Rhodanese/Cell cycle control phosphatase 52799 - (Phosphotyrosine protein) phosphatases II	0.001348	INHERITED FROM: cylindrospermopsin
57184,57603 57184 - Growth factor receptor domain 57603 - FnI-like domain	0.002021	INHERITED FROM: Fluorouracil
100920,100934 100920 - Heat shock protein 70kD (HSP70), peptide-binding domain 100934 - Heat shock protein 70kD (HSP70), C-terminal subdomain	0.002021	INHERITED FROM: Fluorouracil
57586,57586 57586 - TNF receptor-like 57586 - TNF receptor-like	0.00427	INHERITED FROM: Fluorouracil
47954,47954 47954 - Cyclin-like 47954 - Cyclin-like	0.004409	INHERITED FROM: Fluorouracil
47454,57959 47454 - A DNA-binding domain in eukaryotic transcription factors 57959 - Leucine zipper domain	0.009374	INHERITED FROM: Fluorouracil
57440,57440 57440 - Kringle-like 57440 - Kringle-like	0.01078	INHERITED FROM: Fluorouracil
90123,52540 90123 - ABC transporter transmembrane region 52540 - P-loop containing nucleoside triphosphate hydrolases	0.01936	INHERITED FROM: Fluorouracil

Supra-domain (Triple) in N- to C-terminal order

Highlighted in gray are those with FDR>0.001

Supra-domain (Triple) in N- to C-terminal order	FDR (all)	Annotation (direct or inherited)
57924,57924,57924 57924 - Inhibitor of apoptosis (IAP) repeat 57924 - Inhibitor of apoptosis (IAP) repeat 57924 - Inhibitor of apoptosis (IAP) repeat	0	DIRECT
57184,52058,57184 57184 - Growth factor receptor domain 52058 - L domain-like 57184 - Growth factor receptor domain	0	DIRECT
52058,57184,52058 52058 - L domain-like 57184 - Growth factor receptor domain 52058 - L domain-like	0.00003471	DIRECT
57586,57586,57586 57586 - TNF receptor-like 57586 - TNF receptor-like 57586 - TNF receptor-like	0.001909	INHERITED FROM: Fluorouracil
53067,100920,100934 53067 - Actin-like ATPase domain 100920 - Heat shock protein 70kD (HSP70), peptide-binding domain 100934 - Heat shock protein 70kD (HSP70), C-terminal subdomain	0.002021	INHERITED FROM: Fluorouracil